一位晚期患者今年53岁的吴某来自扬州农村,年初时其家人突然发现患者脸色发黄,当时未予特殊重视,不料症状逐渐加重,患者自觉乏力,食欲明显下降,到当地医院就诊,被诊断为肝门部胆管癌,已丧失最佳手术时机,医生委婉告诉其家人,预计生存时间3个月左右。抱着最后一线希望,吴某在家人陪同下慕名来到南京鼓楼医院就诊。该院的专家团队为吴某成功实施了新辅助放化疗联合肝移植术,术后患者各项肝功能指标迅速恢复正常。 A 53-year-old patient from late age Wu, a 53-year-old from rural areas in Yangzhou, the beginning of the year when his family suddenly found the patient’s face yellow, was not given special attention, but gradually increased symptoms, patients consciously fatigue, appetite decreased significantly to the local hospital for treatment was Diagnosis of hilar cholangiocarcinoma, has lost the best timing of surgery, the doctor euphemistically told their families, is expected to survive about 3 months. Hold the last glimmer of hope, Wu accompanied by his family came to Nanjing Gulou hospital. The hospital’s team of experts for the successful implementation of Wu new neoadjuvant chemoradiotherapy combined with liver transplantation, postoperative patients with various liver function indicators quickly returned to normal.